Biopsy Diagnostics LLC is categorized under Pathological Laboratories in Ridgeland, SC and active since 2002.
Biopsy Diagnostics LLC was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Peter White at the company’s single location by writing to 122 Riverwalk Boulevard # A, Ridgeland, South Carolina SC 29936 or by phoning (843) 379-2939. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biopsy Diagnostics LLC |
Contact Person: | Peter White |
Address: | 122 Riverwalk Boulevard # A, Ridgeland, South Carolina 29936 |
Phone Number: | (843) 379-2939 |
Website Address: | auroradx.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Pathological Laboratories |
SIC Code: | 8071 |
NAICS Code: | 621511 |
Share This Business: |
Biopsy Diagnostics LLC was started in 2002 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Peter White for inquiries that concern Biopsy Diagnostics LLC by calling the company number (843) 379-2939, as your correspondence is most welcome. Additionally, the physical location of the single location of Biopsy Diagnostics LLC can be found at the coordinates 32.319867,-80.93552 as well as the street address 122 Riverwalk Boulevard # A in Ridgeland, South Carolina 29936.
For its online presence, you may visit Biopsy Diagnostics LLC’s website at auroradx.com and engage with its social media outlets through on Twitter and on Facebook.